Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Apothecary Pharma LLC recalls Tirzepatide Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
Lack of Assurance of Sterility
Products
  • Tirzepatide Injection
Where it was sold

Nationwide within the United States

Nationwide

Units affected
22 vials
About this recall
Tirzepatide Injection, 18mg/mL, 4 mL Sterile Multi-Dose Vial, Rx only, Apothecary Pharma, LLC, 1913 Evans Road, Cary, NC 27513, NDC 85091-001-18.